Tesofensine 0.5 mg also looks encouraging, matching the ordinary weight loss accomplished by qnexa with what appears to be exceptional tolerability since just 16% of individuals ceased from obtaining the treatment over 24 weeks.Subjects: RatsUnfortunately, this research was halted by the NIH IRB as a result of factors unconnected to…...